Katge Farhin A, Patil Devendra P
Department of Pedodontics and Preventive Dentistry, Terna Dental College, Navi Mumbai, Maharashtra, India.
Department of Pedodontics and Preventive Dentistry, Terna Dental College, Navi Mumbai, Maharashtra, India.
J Endod. 2017 Apr;43(4):507-513. doi: 10.1016/j.joen.2016.11.026. Epub 2017 Feb 16.
The purpose of this study was to compare Biodentine and mineral trioxide aggregate (MTA) for direct pulp capping in young permanent molars by clinical and radiographic evaluation in 7- to 9-year-old children.
In 50 patients, 29 patients with bilateral asymptomatic first permanent molars with carious involvement were selected. According to split mouth design, these patients were then divided into 2 groups, Biodentine group (right side) and MTA group (left side). The pulp-capping procedure was performed by using Biodentine and MTA in 58 asymptomatic bilateral permanent molars with pulp exposure. At each recall (baseline, 6 and 12 months), treatment outcome was assessed clinically through pulpal sensitivity tests as well as radiographically to evaluate dentin bridge formation.
The study reported 100% success rate with both Biodentine and MTA at baseline and 6- and 12-month follow-up on the basis of clinical and radiographic parameters. These findings were statistically non-significant (P < .05) between both groups (Biodentine and MTA). Radiographically, dentin bridge formation was not evident with both groups at baseline, but it was evident after 6- and 12-month follow-up. These findings were statistically non-significant (P < .05) in both Biodentine and MTA groups.
This study reported 100% success rate with both MTA and Biodentine when used as direct pulp-capping agent in first permanent molars in 7- to 9-year-old children. The major limitations of the study were smaller sample size and short follow-up period.
本研究的目的是通过对7至9岁儿童的临床和影像学评估,比较生物活性玻璃陶瓷(Biodentine)和三氧化矿物凝聚体(MTA)用于年轻恒牙直接盖髓的效果。
选取50例患者,其中29例双侧无症状的第一恒磨牙有龋损。根据双侧对照设计,将这些患者分为两组,生物活性玻璃陶瓷组(右侧)和MTA组(左侧)。对58颗无症状且牙髓暴露的双侧恒磨牙分别使用生物活性玻璃陶瓷和MTA进行盖髓治疗。在每次复诊(基线、6个月和12个月)时,通过牙髓敏感性测试进行临床评估,并通过影像学检查评估牙本质桥的形成情况。
根据临床和影像学参数,该研究报告在基线、6个月和12个月随访时,生物活性玻璃陶瓷和MTA的成功率均为100%。两组(生物活性玻璃陶瓷组和MTA组)之间的这些结果在统计学上无显著差异(P < 0.05)。影像学检查显示,两组在基线时均未见到明显的牙本质桥形成,但在6个月和12个月随访后可见。生物活性玻璃陶瓷组和MTA组的这些结果在统计学上均无显著差异(P < 0.05)。
本研究报告,在7至9岁儿童的第一恒磨牙中,生物活性玻璃陶瓷和MTA作为直接盖髓剂的成功率均为100%。本研究的主要局限性在于样本量较小和随访期较短。